Evidence map›Paper›PMID 16199661›Full record

ArticleProtein science : a publication of the Protein Society2005

High-affinity fragment complementation of a fibronectin type III domain and its application to stability enhancement.

Sanjib Dutta, Vincent Batori, Akiko Koide, Shohei Koide

Abstract readEvaluation Study
In one paragraph

Article in Protein science : a publication of the Protein Society, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Adnectins: engineered target-binding protein therapeutics.Protein engineering, design & selection : PEDS · 2011
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sanjib DuttaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.
Vincent Batori
Akiko Koide
Shohei Koide

Funding

ARTIFICIAL MINIANTIBODIES--FROM DESIGN TO STRUCTURER29GM055042 · NIGMS · UNIVERSITY OF ROCHESTER · PI KOIDE, SHOHEI · 1997 to 2001
$223k
NIDDK NIH HHS DK 62316NIGMS NIH HHS GM 55042
6 · The paper itself

Abstract

The tenth fibronectin type III (FN3) domain of human fibronectin (FNfn10), a prototype of the ubiquitous FN3 domain, is a small, monomeric beta-sandwich protein. In this study, we have bisected FNfn10 in each loop to generate a total of six fragment pairs. We found that fragment pairs bisected at multiple loops of FNfn10 show complementation in vivo as tested with a yeast two-hybrid system. The dissociation constant of these fragment pairs determined in vitro were as low as 3 nM, resulting in one of the tightest fragment complementation systems reported so far. Furthermore, we show that the affinity of fragment complementation is correlated with the stability of the uncut parent protein. Exploring this correlation, we screened a yeast two-hybrid library of one fragment and identified mutations that suppress the effect of a destabilizing mutation in the other fragment. One of the identified mutations significantly increased the stability of the uncut wild-type protein, proving that fragment complementation can be used as a novel strategy for the selection of proteins with enhanced stability.

Indexed as

Amino Acid SequenceFibronectinsHumansMolecular Sequence DataMutationProtein EngineeringProtein FoldingProtein Structure, TertiaryTerminology as TopicTwo-Hybrid System TechniquesFibronectins

Identifiers

PMID16199661
PMCPMC2253215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.